Revision history of "SARSCoV2COVID19 in multiple sclerosis patients obtaining diseasemodifying treatments"

From EECH Central
Jump to: navigation, search

Diff selection: Mark the radio boxes of the revisions to compare and hit enter or the button at the bottom.
Legend: (cur) = difference with latest revision, (prev) = difference with preceding revision, m = minor edit.

  • (cur | prev) 09:03, 20 April 2024‎ Smokecheck26 (Talk | contribs)‎ . . (3,464 bytes) (+3,464)‎ . . (Created page with "1ng/ml (95% CI Forty three.5-57.3ng/ml). These types of dasatinib exposures just weren't related to elevated dexamethasone lcd publicity throughout nonleukemia-bearing these a...")
Retrieved from "http://eechcentral.simhq.com/index.php?title=SARSCoV2COVID19_in_multiple_sclerosis_patients_obtaining_diseasemodifying_treatments"